Second annual JBC Methods Madness tournament begins next week
Calling all scientists! The Journal of Biological Chemistry’s second annual Methods Madness tournament is here.
Last year’s tournament came down to the wire with #TeamCryo scraping by #TeamMassSpec to be crowned the first ever champion. Can #TeamCryo repeat this year? Will #TeamMassSpec get revenge? Will both be upset by a new contender? Now is your chance to decide who makes it through.
The madness begins on Monday. (See tournament schedule below). Submit your bracket by Sunday for a chance to win a $100 gift card.
Round 1: The Scientific 16
Vote for your favorite methods by participating in polls posted by .
Monday, March 15
9 a.m. – #TeamMassSpec vs. #TeamFRET
2 p.m. – #TeamImmuno vs. #TeamXRC
Tuesday, March 16
9 a.m. – #TeamCryo vs. #TeamMachine
2 p.m. – #TeamiPSC vs. #TeamLiveCell
Wednesday, March 17
9 a.m. – #TeamPCR vs. #TeamChroma
2 p.m. – #TeamCloning vs. #TeamNMR
Thursday, March 18
9 a.m. – #TeamCRISPR vs. #TeamSuperRes
2 p.m. – #TeamOmics vs. #TeamOpto
All times Eastern.
A note about JBC methods
It's well known that science progresses by building on the shoulders of those who came before. That's especially true for papers that report new tools — genetic constructs, small molecules, model organisms, etc. — that can be directly used by colleagues to jump-start a new project or resolve a technical hurdle. And at JBC, our high standards for rigor and reproducibility mean that readers can trust published tools to work as promised.
— Lila Gierasch, JBC editor-in-chief
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.
Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.
How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.
Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.
Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.
Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.